Literature DB >> 16709965

A new human genotype prone to variant Creutzfeldt-Jakob disease.

Kumanan Wilson, Maura N Ricketts.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16709965      PMCID： PMC1463933          DOI： 10.1136/bmj.332.7551.1164

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Predicted vCJD mortality in Great Britain.

Authors:  A C Ghani; N M Ferguson; C A Donnelly; R M Anderson
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

Review 2.  Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies.

Authors:  K Wilson; C Code; M N Ricketts
Journal:  BMJ       Date:  2000-07-01

3.  The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease.

Authors:  Kumanan Wilson; Maura N Ricketts
Journal:  Transfusion       Date:  2004-10       Impact factor: 3.157

4.  Consensus conference on vCJD screening of blood donors: report of the panel.

Authors:  Jeffrey McCullough; David Anderson; Denize Brookie; Jean-Pierre Bouchard; Dean Fergusson; Jean Joly; Nuala Kenny; David Lee; Harry Megânn; David Page; Daniel Reinharz; John R Williams; Kumanan Wilson
Journal:  Transfusion       Date:  2004-05       Impact factor: 3.157

5.  Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study.

Authors:  James W Ironside; Matthew T Bishop; Kelly Connolly; Doha Hegazy; Suzanne Lowrie; Margaret Le Grice; Diane L Ritchie; Linda M McCardle; David A Hilton
Journal:  BMJ       Date:  2006-04-10

Review 6.  Iatrogenic Creutzfeldt-Jakob disease at the millennium.

Authors:  P Brown; M Preece; J P Brandel; T Sato; L McShane; I Zerr; A Fletcher; R G Will; M Pocchiari; N R Cashman; J H d'Aignaux; L Cervenáková; J Fradkin; L B Schonberger; S J Collins
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

7.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

8.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

Authors:  C A Llewelyn; P E Hewitt; R S G Knight; K Amar; S Cousens; J Mackenzie; R G Will
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

9.  Novel methods for disinfection of prion-contaminated medical devices.

Authors:  Guillaume Fichet; Emmanuel Comoy; Christelle Duval; Kathleen Antloga; Capucine Dehen; Aurore Charbonnier; Gerald McDonnell; Paul Brown; Corinne Ida Lasmézas; Jean-Philippe Deslys
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

10.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.

Authors:  Alexander H Peden; Mark W Head; Diane L Ritchie; Jeanne E Bell; James W Ironside
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321
View more
  3 in total

Review 1.  An overview of human prion diseases.

Authors:  Muhammad Imran; Saqib Mahmood
Journal:  Virol J       Date:  2011-12-24       Impact factor: 4.099

2.  Problems with precaution: the transfusion medicine experience.

Authors:  Kumanan Wilson; Katherine M Atkinson; Dean A Fergusson; Adalsteinn Brown; Alan Forster; Malia S Q Murphy; Alan T Tinmouth; Jennifer Keelan
Journal:  J Risk Res       Date:  2017-07-29

Review 3.  Epidemiological characteristics of human prion diseases.

Authors:  Cao Chen; Xiao-Ping Dong
Journal:  Infect Dis Poverty       Date:  2016-06-02       Impact factor: 4.520
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.